CRC has an immunosuppressive TME which helps prevent the event of a successful reaction to ICB therapies. There is thus an urgent need to identify the techniques reprogram this suppressive TME as a way to boost immunotherapy efficacy. In The existing review, we applied CRISPR KO screens to find genes https://richardq851ulb8.sunderwiki.com/user